Search research articles
Contact Us
Filters
Showing results (181-190 of 199) with videos related to
Page
of 20
Sort By:
Archives of Biochemistry and Biophysics
|
May 1, 1990
Purification and characterization of human plasminogen activator inhibitor type I expressed in Saccharomyces cerevisiae
S J Gardell, T R Hare, J H Han, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing
|
January 1, 1990
The Minnesota project: a focused approach to ambulatory quality assessment
L I Solberg, K E Peterson, R W Ellis, et al.
Journal of Virology
|
March 1, 1986
New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products
A J Davison, C M Edson, R W Ellis, et al.
The Journal of Biological Chemistry
|
October 15, 1990
Characterization of recombinant tick anticoagulant peptide. A highly selective inhibitor of blood coagulation factor Xa
M P Neeper, L Waxman, D E Smith, et al.
Vaccine
|
November 1, 1995
Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation
K U Jansen, M Rosolowsky, L D Schultz, et al.
Archives of Biochemistry and Biophysics
|
February 1, 1994
Structural characterization of the N-glycans of a humanized anti-CD18 murine immunoglobulin G
C C Ip, W J Miller, M Silberklang, et al.
Vaccine
|
February 1, 1991
Antibody assays suitable for assessing immune responses to live varicella vaccine
P J Provost, D L Krah, B J Kuter, et al.
Annals of the New York Academy of Sciences
|
May 2, 1994
Using molecular genetics to improve the production of recombinant proteins by the yeast Saccharomyces cerevisiae
L D Schultz, H Z Markus, K J Hofmann, et al.
Journal of Medical Virology
|
May 1, 1989
Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein
E A Emini, V Larson, J Eichberg, et al.
Virology
|
October 1, 1988
Antigenic analysis of the Epstein-Barr virus major membrane antigen (gp350/220) expressed in yeast and mammalian cells: implications for the development of a subunit vaccine
E A Emini, W A Schleif, M E Armstrong, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 199) with videos related to
Sort By:
Page
of 20
Archives of Biochemistry and Biophysics
|
May 1, 1990
Purification and characterization of human plasminogen activator inhibitor type I expressed in Saccharomyces cerevisiae
S J Gardell, T R Hare, J H Han, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing
|
January 1, 1990
The Minnesota project: a focused approach to ambulatory quality assessment
L I Solberg, K E Peterson, R W Ellis, et al.
Journal of Virology
|
March 1, 1986
New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products
A J Davison, C M Edson, R W Ellis, et al.
The Journal of Biological Chemistry
|
October 15, 1990
Characterization of recombinant tick anticoagulant peptide. A highly selective inhibitor of blood coagulation factor Xa
M P Neeper, L Waxman, D E Smith, et al.
Vaccine
|
November 1, 1995
Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation
K U Jansen, M Rosolowsky, L D Schultz, et al.
Archives of Biochemistry and Biophysics
|
February 1, 1994
Structural characterization of the N-glycans of a humanized anti-CD18 murine immunoglobulin G
C C Ip, W J Miller, M Silberklang, et al.
Vaccine
|
February 1, 1991
Antibody assays suitable for assessing immune responses to live varicella vaccine
P J Provost, D L Krah, B J Kuter, et al.
Annals of the New York Academy of Sciences
|
May 2, 1994
Using molecular genetics to improve the production of recombinant proteins by the yeast Saccharomyces cerevisiae
L D Schultz, H Z Markus, K J Hofmann, et al.
Journal of Medical Virology
|
May 1, 1989
Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein
E A Emini, V Larson, J Eichberg, et al.
Virology
|
October 1, 1988
Antigenic analysis of the Epstein-Barr virus major membrane antigen (gp350/220) expressed in yeast and mammalian cells: implications for the development of a subunit vaccine
E A Emini, W A Schleif, M E Armstrong, et al.
Page
of 20